Cardiovascular Risk Factor
355
19
29
237
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Published Results
33 trials with published results (9%)
Research Maturity
237 completed trials (67% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.7%
13 terminated out of 355 trials
94.8%
+8.3% vs benchmark
5%
16 trials in Phase 3/4
14%
33 of 237 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 237 completed trials
Clinical Trials (355)
Biomedical Research Informatics Centre for Cardiovascular Sciences (The BRICCS Study)
Consumption of Oral Artificial Sweeteners on Platelet Aggregation and Polyol Excretion
Body Weight, Sleep, and Heart Health
The Clinical Referral to Activity Study
Southampton Women's Survey
Virtual Lifestyle Intervention for Weight Management and Cardiovascular Heal
The Potassium Supplementation Study
Visualizing Vascular Mechanisms of Salt Sensitivity
Effects of Breaking up Prolonged Sitting on Postprandial Cardiometabolic Disease Risk Markers in South Asian Adults
Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors
Relationship Between Nutritional Status, Physical Activity and Periodontal Status
Using Big Data to Conduct Innovative Cardiovascular Clinical Trials
Short Term Choline and Cardiovascular Health
Short Term Ketone Supplementation and Cardiometabolic Health
Choline Supplementation and Cardiovascular Health
Substituting Sitting With Standing and Walking in Free-living Conditions Improves Daily Glucose Profile in South Asians
Implications of the Presence of Non-obstructive Atherosclerotic Plaques on Platelet and Vascular Reactivity
An Evaluation of Insomnia Treatment to Reduce Cardiovascular Risk in Patients With Posttraumatic Stress Disorder
Selected Disorders and Sleep Bruxism
Mechanisms Underlying the Protective Vascular Effects of Dietary Potassium in Humans